Dinuclear Ru(II) complexes [(p-cymene)2(RuCl)2L1]2X (X = BF4 (Ru1); X = PF6 (Ru2)) and mononuclear [(p-cymene)(RuCl)L2]BF4 (Ru3) (where L1 = N,N′-(3,3′,5,5′-tetraisopropyl-[1,1′-biphenyl]-4,4′-diyl)bis(1-(pyridin-2-yl)methanimine); L2 = N-(2,6-diisopropyl-phenyl)-1-(pyridin-2-yl)-methanimine) have been synthesized and characterized by spectroscopic and analytical techniques. Dinuclear Ru1 and Ru2 orchestrate direct transformation of 2-nitrobenzyl alcohols to quinolines under mild conditions with significant efficiency even when employed at a minimal catalyst loading of 0.1 mol %. Proportional experiments carried out with the corresponding mononuclear complex Ru3 by keeping the Ru content the same (0.2 mol % of Ru3) reveal superior activity by the bimetallic system Ru1 for the one-pot quinoline synthesis. Late-stage functionalization of bioactive steroids and scale-up synthesis demonstrate the practical applicability of the present catalyst system. A probable mechanism of this conversion is proposed based on trapping of many of the intermediates by ESI-mass spectroscopy. These mechanistic studies have further been substantiated by ReactIR studies by monitoring the progress of the reaction in real time.
No takes yet. Share an insight, caveat, or question.
Deshmukh et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: